BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 5358572)

  • 1. Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
    Radó JP; Takó J; Szabó T; Bános C
    Endokrinologie; 1969; 54(1):26-35. PubMed ID: 5358572
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of diuretic and antidiuretic properties of furosemide in diabetes insipidus.
    Radó JP; Bános C; Marosi J; Borbély L; Takó J
    Endokrinologie; 1968; 53(3):253-60. PubMed ID: 5713386
    [No Abstract]   [Full Text] [Related]  

  • 3. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the antidiuretic response to intracarotid infusions of various hypertonic solutions in the conscious goat.
    Eriksson L; Fernández O; Olsson K
    Acta Physiol Scand; 1971 Dec; 83(4):554-62. PubMed ID: 5160134
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical value of the combination of vasopressin and chlorpropamide in a patient with "refractory" diabetes insipidus.
    Radó JP; Szende L; Takó J; Góth E; Fövényi J
    Endokrinologie; 1972 Feb; 59(2):203-12. PubMed ID: 5036075
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of prolonged administration of vasopressin on plasma sodium and on renal excretion of electrolytes and water.
    Chan WY
    J Pharmacol Exp Ther; 1971 Jul; 178(1):141-51. PubMed ID: 5087392
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of hypertonic saline, clopamide and furosemide for evaluation of the concentrating defect in pitressin-treated diabetes insipidus.
    Radó JP; Szende L
    Med Exp Int J Exp Med; 1968; 18(3):185-90. PubMed ID: 5756717
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intravenous diazoxide and chlorpropamide on renal function in man.
    Radó JP; Szende L; Takó J; Halmos T
    Am Heart J; 1973 Jun; 85(6):755-66. PubMed ID: 4702664
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of furosemide on the osmolality of the urine and the composition of renal tissue.
    Fraser AG; Cowie JF; Lambie AT; Robson JS
    J Pharmacol Exp Ther; 1967 Dec; 158(3):475-86. PubMed ID: 6073231
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between the dose of chlorpropamide administered intravenously and the antidiuretic effect in diabetes insipidus.
    Radó JP; Borbély L; Szende L; Takó J
    Pharmacology; 1970; 3(2):122-8. PubMed ID: 5427315
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal concentrating ability during hypertonic saline and mannitol diuresis in the rabbit.
    Barraclough MA; Guignard JP; Jones NF
    J Appl Physiol; 1970 Feb; 28(2):209-12. PubMed ID: 5413307
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of carbamazepine and clofibrate antidiuretic effect by mannitol osmolar clearance.
    Simon J; Zamora I; Mendizabal S; Bartolome V
    Helv Paediatr Acta; 1979 Sep; 34(4):329-38. PubMed ID: 521299
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of antidiuretic hormone on the distribution of nephron filtration rates in rats with hereditary diabetes insipidus.
    Davis JM; Schnermann J
    Pflugers Arch; 1971; 330(4):323-34. PubMed ID: 5169237
    [No Abstract]   [Full Text] [Related]  

  • 14. Pitfalls in the localization of diuretic action. Effects on water excretion.
    Migone L; Andreucci VE; Carrara GC; Pesente L
    Clin Nephrol; 1973; 1(5):319-31. PubMed ID: 4543713
    [No Abstract]   [Full Text] [Related]  

  • 15. [Angiotensin II: its possible role in homeostasis of extracellar fluid volume].
    Agnoli GC; Cariani A; Garutti C; Montini T
    G Clin Med; 1974 Mar; 55(3):161-236. PubMed ID: 4372117
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical disorders of urine concentration and dilution.
    Harrington JT; Cohen JJ
    Arch Intern Med; 1973 Jun; 131(6):810-25. PubMed ID: 4574887
    [No Abstract]   [Full Text] [Related]  

  • 18. Micropuncture studies on the influence of antidiuretic hormone on tubular fluid reabsorption in rats with hereditary diabetes insipidus.
    Schnermann J; Valtin H; Thurau K; Nagel W; Horster M; Fischbach H; Wahl M; Liebau G
    Pflugers Arch; 1969; 306(2):103-18. PubMed ID: 5813389
    [No Abstract]   [Full Text] [Related]  

  • 19. Inherited forms of diabetes insipidus and diagnostic drug applications.
    Relkin R
    Ann N Y Acad Sci; 1968 Jul; 151(2):880-6. PubMed ID: 5263695
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of chlorpropamide action in diabetes insipidus.
    Miller M; Moses AM
    J Clin Endocrinol Metab; 1970 Apr; 30(4):488-96. PubMed ID: 5435288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.